Poisonous mushrooms; a review of the most common intoxications;Hongos venenosos; una revisión de las intoxicaciones más comunes

Nutricion Hospitalaria

Volumn 27, Issue 2, 2012, Pages 402-408

  Lima, A D L ^a   Costa Fortes, R ^a   Garbi Novaes, M R C ^a   Percario S ^b  

^a UNIVERSITY OF BRASILIA   (Brazil)

^b FEDERAL UNIVERSITY OF PARÁ   (Brazil)

Author keywords

Mushrooms; Review; Toxicity; Toxins

Indexed keywords

BASIDIOMYCOTA;

MYCOTOXIN; NEUROTOXIN;

ADOLESCENT; ADULT; AGARICALES; AGED; ANIMAL; CASE REPORT; CHEMISTRY; CLASSIFICATION; FEMALE; HUMAN; MALE; MIDDLE AGED; MUSHROOM POISONING; REVIEW;

ADOLESCENT; ADULT; AGARICALES; AGED; ANIMALS; FEMALE; HUMANS; MALE; MIDDLE AGED; MUSHROOM POISONING; MYCOTOXINS; NEUROTOXINS; YOUNG ADULT;

EID: 84858723624     PISSN: 02121611     EISSN: 16995198     Source Type: Journal    
DOI: 10.3305/nh.2012.27.2.5328     Document Type: Review

References (52)

1. Lull C. Wichers HJ, Savelkoul HFJ. Antiinflamatory and immunomodulating properties of fungal metabolites. Mediat Inflamm 2005; 2005 (2): 63-80.
2. Karlson-Stiber and Persson. Cytotoxic fungi - an overview. Toxicon 2003; 42 (4): 339-49.
3. Flesch F and Saviuc P. Intoxication par les champignon: principaux syndromes et traitment. EMC-Médecine 2004; 1: 70-9.
4. Wasser SP. Review of medicinal mushrooms advances: good news from old allies. HerbalGram 2002; 56: 28-33.
5. Miyaji CK, Colus IMS. Mushroom shiitake, is it a mutagenic or antimutagenic agent? Semina: Sci Biol Saúde 2001; 22 jan/dez: 11-17.
6. Delu MAF, Dias ES, Schwan RF, Vilas Boas EVB. Avaliação da coloração de basidiocarpos desidratados de Agaricus blazei segundo a escala de Munsell. Ciênc Agrotec 2006; 30 (1): 162-5.
7. Nieminen P, Kirsi M and Mustonen AM. Suspected Myotoxicity of edible wild mushrooms. Experimental Biology and Medicine 2006; 231: 221-8.
8. th Edition. McGraw-Hiil Companies, Inc. USA
9. White J, Warrel D, Eddleston M, Currie BJ, White IM, Isbister GK. Clinical toxinology - Where are we now? 2003; 41 (3): 263-76.
10. Wong JH and Ng TB. Toxins from Basiodiomycete fungi (mushroom): amatoxins, phallotoxins and virotoxins. Handbook of Biologically Active Peptides. 2006; Chapter 2: 131-5.
11. Escudié L, Francoz C, Vinel JP, Moucari R, Cournot M, Paradis V, Sauvanet A, Belghiti J, Valla D, Bernuau J and Durand F. Amanita phalloides poisoning: Reassessment of prognostic factor and indications for emergency liver transplantation. J Hepatol 2007; 46: 466-73.
12. Mas A. Mushrooms, amatoxins and the liver. J Hepatol 2005; 42: 166-9.
13. Tsujikawa K, Mohri H, Kuwayama K, Miyaguchi H, Iwata Y, Gohda A, Fukushima S, Inoue H and Kishi T. Analyses of hallucinogenic constituents in Amanita mushrooms circulated in Japan. Forensic Sci Int 2006; 264: 172-8.
14. Michelot D and Melendez-Howell LM. Amanita muscaria: chemistry, biology and ethnomycology. Mycol Res 2003; 107 (2): 131-46.
15. Tsujikawa K, Kuwayama K, Kanamori T, Iwata Y, Inoue H, Yoshida T and Kishi T. Determination of muscimol and ibotenic acid in Amanita mushrooms by high-performance liquid chromatography and liquid-chromatography-tandem mass spectrometry. J Chromatogr 2007; 852: 430-5.
16. Stormer FC, Koller GE and Janak K. Ibotenic acid in Amanita muscaria spores and caps. Mycologist 2004; 18: 114-17.
17. Satora L, Pach D, Cizowski K and Winnik L. Panther cap Amanita pantherina poisoning case report and review. Toxicon 2006; 47: 605-7.
18. Bessard J, Saviuc P, Chane-Yene Y, Monnet S, Bessard G. Mass spectrometric determination of acromelic acids A from a new poisonous mushroom: Clitocybe amoenolens. J Chromatogr A 2004; 1055: 99-107.
19. Saviuc P, Dematteis M, Mezin P, Danel V, Mallaret M. Toxicity of the Clitocybe amoenolens mushroom in the rat. Rev Hum Toxicol 2003; 45 (4): 180-2.
20. Taguchi T, Tomotoshi K and Mizumura K. Excitatory actions of mushroom poison (acromelic acid) on unmyelinated muscular afferents in the rat. Neurosci Lett 2009; 456: 69-73.
21. Dehay MH, Mareville FS, Assez N, Dherbecourt V and Goldstein P. Syndrome muscarinique par ingestion de champignon: à propos de deux cas dont un mortel. Eur J Emerg 2009; 22: 18-23.
22. Danel VC, Saviu PF and Garon D. Main features of Cortinarius spp. poisoning: a literature review. Toxicon 2001; 39: 1053-60.
23. Tegzes JH and Puschner B. Toxic mushrooms. Vet Clin Small Anim 2002; 32: 397-407.
24. Wornle M, Angstwurm MWA and Sitter T. Treatment of intoxication with Cortinarius speciosissimus using and antioxidant therapy. Am J Kidney Dis 2004; 43 (4): e3-e6.
25. Berger KJ and Guss DA. Mycotoxins revisited: part II. J Emerg Med 2005; 28 (2): 175-183.
26. Bédry R and Saviuc P. Intoxications graves par les champignons à l'exception du syndrome phalloidien. Reánimation 2002; 11: 524-32.
27. Keller T, Schneide A, Regenscheit P, Dirnhofer R, Rucher T, Jaspers J and Kisser W. Analysis of psilocybin and psilocin in Psilocybe subcubensis GUZMÁN by ion mobility spectrometry and gas chromatography - mas spectrometry. Forensic Sci Int 1999; 99: 93-105.
28. Zuzek MC, Macek P, Sepcic K, Cestnik V, Franquez R et al. Toxic and lethal effects of ostreolysin, a cytolytic protein from edible oyster mushroom (Pleurotus ostreatus), in rodents. 2006; 48(3): 264-71.
29. Shibata Y, Kashiwagi B, Arai S, Fukabori Y, Suzuki K. Administration of extract of mushroom Phellinus linteus induces prostate enlargement with increase in stromal component in experimentally developed rat model of benign prostatic hyperplasia. Urology 2005; 66 (2): 455-60.
30. Walton K, Coombs MM, Walker R, Ioannides C. The metabolism and bioactivation of agaritine and of other mushroom hydrazines by whole mushroom homogenate and by mushroom tyrosinase. Toxicology 2001; 161(3): 165-77.
31. Walton K, Coombs MM, Walker R, Ioannides C. Bioactivation of mushroom hydrazines to mutagenic products by mammalian and fungal enzymes. Mutat Res 1997; 381 (1): 131-39.
32. Sasaki H, Akiyama H, Yoshida Y, Kondo K, Amakura Y, Kasahara Y, Maitani T. Sugihiratake Mushroom (Angel's Wing Mushroom)-Induced Cryptogenic Encephalopathy may Involve Vitamin D Analogues. Biol Pharm Bull 2006; 29 (12): 2514-18.
33. Novaes MRCG, Fortes RC. Efeitos da Suplementação dietética com cogumelos Agaricales e outros fungos medicinais na terapia contra o câncer. Rev Bras Cancerol 2006; 52 (4): 363-71.
34. Chodorowski Z, Waldaman W and Anand S. Acute poisoning with Tricholoma equestre. Przegl Lek 2002; 59 (4-5): 386-7.
35. Benitez-Mácias JF, García-Gil D, Brun-Romero FM and Nogué-Xarau S. Intoxicaciones agudas por setas. Rev Clin Esp 2009; 209 (11): 542-9.
36. Saviuc P, Fouilhe Sam-Lai N and Danel V. Champignons toxiques: les nouveaux syndromes. Journal Europee des Urgences 2003; 16 (1): 13-7.
37. Wessely M, Schönermarck U, Raziorrouh B, Jung MC, Samtleben. Orellanus syndrome: a rare cause of acute renal failure. Dtsch Med Wochenschr 2007; 132 (37): 1880-2.
38. Mount P, Harris G, Sinclair R, Finlay M, Becker GJ. Acute renal failure following ingestion of wild mushrooms. Intern Med J 2002; 32: 182-90.
39. Giannini L, Vannacci A, Missaneli A, Mastroianni R, Mannaioni PF, Moroni F, Masini E. Amatoxin poisoning: a 15-year retrospective analysis and follow-up evaluation of 105 patients. Clin Toxicol (Phila) 2007; 45 (5): 539-42.
40. Ennecker-Jans AS, Van Daele PL, Blonk MI, Varin DS, Van Laar JA. Amatoxin poisoning due to soup from personally picked deathcap mushrooms (Amanita phalloides). Ned Tijdschr Geneeskd 2007; 151 (13): 764-8.
41. Aygul N, Duzenli MA, Ozdemir K and Altunkeser BB. A case report of unusual complication of Amanita phalloides poisoning: Development of cardiogenic shock and its successful treatment with intra-aortic balloon counterpulsation. Toxicon 2010; 55: 630-2.
42. Bedry R, Baudrimont I, Defieux G, Creppy EE, Pomies JP, Dupon M, Gabinski C, Chapalain JC. Wild mushroom intoxication as a cause of rhabdomyolysis. N Engl J Med 2001; 345 (II): 798-802.
43. Saviuc PF, Danel VC, Moreau PA, Claustre AM, Ducluzeau R, Carpentier PH. Érythermalgie soudaine: cherchez les champignons! Rev Méd Intern 2002; 23: 394-9.
44. Gonmori K and Yoshioka N. The examination of mushroom poisonings at Akita University. Leg Med 2003; 5: S83-S86.
45. Berne S, Sepcic K, Anderluh G, Turk T, Macek P, Ulrih NP. Effect of pH on the pore forming activity and conformational stability of ostreolysin, a lipid raft-binding protein from the edible mushroom Pleurotus ostreatus. Biochem 2005; 44: 11137-47.
46. Wieland T, Gotzendorfer C, Zanotti G, Vaisius AC. The effect of the chemical nature of the side chains of amatoxins in the inhibition of eukaryotic RNA polymerase B. Eur J Biochem 1981; 117: 161-4.
47. Kobayashi N, Endo S, Kobayashi H, Faulstich H, Wieland T, Munekata E. Comparative study on the formation of phalloidin, viroisin and related derivatives in aqueous solution. Eur J Biochem 1995; 232: 726-36.
48. Kondo K, Watanabe A, Akiyama H, Maitani T. The metabolisms of agaritine, a mushroom hydrazine in mice. Food Chem Toxicol 2008; 46: 854-62.
49. Nilson A, Nystrom J, Buvall L, Ebefors K, Bjornson-Granqvist A, Holmdahl J, Haraldsson B. The fungal nephrotoxin Orellanine simultaneously increases oxidative stress and down-regulates cellular defenses. Free Radic Biol Med 2008; 44 (8): 1562-9.
50. Arshadi M, Nilsson C, Magnusson B. Gas chromatography-mass spectrometry determination of the pentafluorobenzoyl derivative of methylhydrazine in false morel (Gyromitra esculenta) as a monitor for the content of the toxin gyromitrin. J Chromatogr 2006; 1125: 229-33.
51. Musshoff F, Madea B and Beike J. Hallucinogenic mushrooms on the German market - simple instructions for examination and identification. Forensic Sci Int 2000; 13: 389-95.
52. Vollenweider FX, Vollenweider-Scherpenhuyzen MFI, Babler A, Vogel H and Hell D. Psilocybin induces schizophrenia-like psychosis in human via serotonin-2 agonist action. Cog Neurosci 1998; 9 (17): 3897-3902.